scispace - formally typeset
P

Paul J. Whiting

Researcher at Pfizer

Publications -  178
Citations -  22171

Paul J. Whiting is an academic researcher from Pfizer. The author has contributed to research in topics: Receptor & GABAA receptor. The author has an hindex of 78, co-authored 174 publications receiving 21463 citations. Previous affiliations of Paul J. Whiting include Merck & Co. & UCL Institute of Neurology.

Papers
More filters
Journal ArticleDOI

Which GABAA-receptor subtypes really occur in the brain?

TL;DR: It is concluded that the number of major subtypes is probably less than ten but their physiological roles have yet to be clearly defined and this represents the next step in GABAA-receptor research.
Journal ArticleDOI

Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype.

TL;DR: This work created genetically modified mice with a diazepam-insensitive α1 subtype and a selective BZ site ligand to explore GABAA receptor subtypes mediating specific physiological effects and revealed that the α1Subtype mediated the sedative, but not the anxiolytic effects of benzodiazepines.
Journal ArticleDOI

DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling.

TL;DR: The disrupted in schizophrenia 1 (DISC1) gene is disrupted by a balanced translocation in a subject diagnosed with schizophrenia and a relative with chronic psychiatric illness and a mechanistic model whereby DISC1 sequesters PDE4B in resting cells and releases it in an activated state in response to elevated cAMP is proposed.
Journal ArticleDOI

Pharmacological characterization of a novel cell line expressing human α4β3δ GABAA receptors

TL;DR: The pharmacology of the stable cell line expressing human alpha(4)beta(3)delta GABA(A) receptor was investigated using whole-cell patch-clamp techniques as discussed by the authors.